PATENT CLAIM ANALYSIS

Application Number: 16013281
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["548", "530000"]

Abstract:
The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.

Claim (Index 34):
The process according to  claim 33  for the preparation of a compound of the formula Ib-1h\u2033 wherein R is H; (i) R 8  is \u2014Cl or \u2014F; and\n R 9  is \u2014H; or \n (ii) R 8  is \u2014F; and\n R 9  is \u2014F; and \n A 0 , A 0\u2032 , A 1 , A 2 , A 3 , A 4  and A 5  are selected from the combinations 1 to 24: Combination no A 0 A 0\u2032 A 1 A 2 A 3 A 4 A 5 1 CH CH C\u2014OCH 3 CH C\u2014NHSO 2 CH 3 CH CH 2 CH CH C\u2014CH 3 C\u2014NHSO 2 CH 3 CH CH CH 3 CH CH C\u2014OCH 3 N CH CH CH 4 CH CH C\u2014OCH 3 N C\u2014OCH 3 N CH 5 C\u2014OCH 3 CH CH N C\u2014OCH 3 N CH 6 CH CH C\u2014OCH 3 N N C\u2014OCH 3 CH 7 CH CH C\u2014OCH 3 CH CH C\u2014CN CH 8 CH CH C\u2014CH 3 CH CH C\u2014CN CH 9 C\u2014F CH C\u2014OCH 3 N N C\u2014OCH 3 CH 10 CH CH CH N CH CH C\u2014OCH 3 11 CH CH CH CH C\u2014NHSO 2 CH 3 CH CH 12 CH CH CH C\u2014NHSO 2 CH 3 CH CH CH 13 CH CH CH N C\u2014OCH 3 N C\u2014OCH 3 15 CH CH C\u2014OCH 3 N CH N CH 16 CH C\u2014OCH 3 C\u2014OCH 3 CH CH CH CH 17 C\u2014OCH 3 CH CH N CH CH C\u2014OCH 3 18 C\u2014OCH 3 CH C\u2014OCH 3 N C\u2014OCH 3 N CH 19 CH CH C\u2014OCH 3 CH C\u2014NHCOCH 3 CH CH 20 CH CH C\u2014CN CH C\u2014OCH 3 C\u2014OCH 3 CH 21 CH CH C\u2014OCH 3 CH C\u2014N(CH 3 )SO 2 CH 3 CH CH 23 CH CH C\u2014OCH 3 N CH N C\u2014OCH 3 24 CH CH C\u2014OCH 3 CH N CH CH wherein the process consists of:\n a) coupling of a compound of formula A \n wherein R is methyl, ethyl, tert-butyl, benzyl, allyl, phenacyl, methoxymethyl, methylthiomethyl, 2-methoxyethoxymethyl, 2-trimethylsilylethyl or tert-butyldiphenylsilyl; and (i) R 8  is \u2014Cl or \u2014F; and\n R 9  is \u2014H; or \n (ii) R 8  is \u2014F; and\n R 9  is F. \n with a compound of formula D, in the presence of a base, and b) (i) treating the compound provided in step a) with a base, an acid or a fluoride; or (ii) hydrolysis of the compound provided in step a); or (iii) hydrogenolysis of the compound provided in step a), to provide a compound of formula Ib-1h\u2033.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.0
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13526337', '15624290', '14763468', '15039323', '15906268']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.784709273496456
- 35 USC 102 Novelty (BERT): 0.5609417382546257
- Combined Prediction Score: 0.762332519972273
- Mean Citation Score: 343.29917
- Max Citation Score: 459.43094
- Similarity Product: 334.6408943711162

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test